Daunorubicin recalls
The FDA has published 2 recalls involving Daunorubicin since 2014. The latest was reported on 25 Aug 2021. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 25 Aug 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why daunorubicin is recalled
Companies
By year
All daunorubicin recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | DAUNOrubicin Hydrochloride Injection 20 mg/ Single Dose vials recalled | Teva Pharmaceuticals USA | Sterility | Nationwide |
| Drug | CLASS II | Daunorubicin Hydrochloride Injection, 20 mg recalled | Teva Pharmaceuticals USA | Other | Nationwide |
Should you stop taking Daunorubicin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.